TransMedics Group Inc (TMDX) stock news · P/E 18, rev $605.5M
TransMedics Group Inc (TMDX) is a medical devices company listed on NASDAQ.
This TMDX news page leads with what TransMedics Group Inc filed — not a scraped headline mill.
No cached 8-K sentence for TMDX yet. We will not pad this page with generic market recap.
Latest reported TMDX revenue for 2025-12-31 was $605.5M. Net income was $190.3M. Revenue was up 37.1% from 2024-12-31 to 2025-12-31. TMDX currently screens at market cap $2.53B and trailing P/E 18.3.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the TMDX stock page; for the tape open the quote page.
TMDX stock news FAQ
What are TMDX's latest revenue and net income?
Latest cached TransMedics Group Inc (TMDX) revenue for Dec 31, 2025 was $605.5M. Net income was $190.3M. Statements: https://lician.com/financials/tmdx
How did TMDX revenue change from the prior cached period?
Cached TransMedics Group Inc (TMDX) revenue was up 37.1% from $441.5M (Dec 31, 2024) to $605.5M (Dec 31, 2025). Statements: https://lician.com/financials/tmdx
What is TMDX's P/E ratio?
TransMedics Group Inc (TMDX) trailing P/E is 18.3 on the latest cached fundamentals snapshot.
What is TMDX's market cap?
TransMedics Group Inc (TMDX) market cap is $2.53B on the latest cached fundamentals snapshot.
What kind of company is TMDX?
TransMedics Group Inc (TMDX) is a medical devices company listed on NASDAQ.
Where is TMDX stock news listed?
Cached stock news for TransMedics Group Inc (TMDX) is listed at https://lician.com/news/tmdx. Filings: https://lician.com/sec/tmdx
Not investment advice.